Among patients with very high use of health care services, readmission rates were not lower for those assigned to a care-transition program compared with usual care.
Medicaid expansion is associated with a reduction in total opioid overdose deaths and with increases in methadone-related mortality.
In an effort to further address the current opioid crisis, the FDA contracted the NASEM to examine existing opioid prescribing guidelines and to help outline the type of research needed to fill the gaps in evidence.
A machine learning system can generate clinically valid alerts for medication errors that might be missed with existing clinical decision support (CDS) systems.
Rural Medicare beneficiaries with complex chronic conditions have higher preventable hospitalization and mortality rates than their urban peers, which is partially explained by reduced access to specialists.
Haymarket Medical Education (HME) has partnered with the American Academy of Family Physicians (AAFP) to expand available continuing education offerings for family physicians.
Prescription opioid use among teens and young adults is higher than expected, with most obtaining the drugs from friends and family.
Seriously ill Medicare enrollees experience considerable financial distress.
In a new report, Engineering, and Medicine, recommendations are presented to address clinician burnout.
The FDA has issued a report assembled by the inter-agency Drug Shortages Task Force to determine the root causes of drug shortages, and to offer recommendations based on the insights from stakeholders in the private and public sectors to help prevent future drug shortages.